Subtype of breast cancer influences sentinel lymph node positivity

被引:2
作者
Kedzierawski, Piotr [1 ,2 ,6 ]
Bocian, Artur [3 ]
Radowicz-Chil, Agnieszka [2 ,4 ]
Huruk-Kuchinka, Anna [1 ]
Mezyk, Ryszard [5 ]
机构
[1] Holycross Canc Ctr, Dept Radiotherapy, Kielce, Poland
[2] Jan Kochanowski Univ, Fac Med & Hlth Sci, Kielce, Poland
[3] Holycross Canc Ctr, Dept Surg, Kielce, Poland
[4] Holycross Canc Ctr, Dept Pathol, Kielce, Poland
[5] Holycross Canc Ctr, Dept Epidemiol, Kielce, Poland
[6] Holycross Canc Ctr, Dept Radiotherapy, 3 Artwinskiego St, PL-25734 Kielce, Poland
关键词
breast cancer; sentinel lymph node biopsy; biological subtype; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMOTHERAPY; METASTASIS; RISK; MANAGEMENT; FEATURES;
D O I
10.5114/aoms.2019.88595
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The purpose of the study was to determine the correlation between biological subtype of breast cancer and the risk of its metastasis to a sentinel lymph node.Material and methods: In the analysed group there were 1018 women with breast cancer, clinically node negative, untreated previously. Luminal A subtype was recognised in 57% of patients. A positive sentinel lymph node was detected in 26.5% of women.Results: In the multivariate analysis only age and tumour size proved to be significant for the entire group, respectively: OR = 0.59, p = 0.0004; OR = 1.96; p < 0.0001. For Luminal A subtype values were OR = 0.51, p = 0.0007; OR = 1.78, p = 0.0045, respectively. For Luminal B patients, in women over 61 years, the risk of sentinel node metastasis probability decreases by 67% and for tumours over 21 mm the probability of positive sentinel node metastasis increases by 117%. Conclusions: According to our analysis luminal breast cancers are most numerous subtypes, and in these cases we expect more frequent instances of metastasis to a sentinel node. Following the most updated and modern procedures of breast cancer patients' treatment a procedure of sentinel lymph node biopsy is used, replacing an aggressive treatment in the axilla region. In regards to our analysis we should be more vigilant in estimation of regional lymph nodes in luminal patients under sixty with high grade tumours and the tumour diameter more than 20 mm.
引用
收藏
页码:618 / 625
页数:8
相关论文
共 35 条
[1]   Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives [J].
Ades, Felipe ;
Zardavas, Dimitrios ;
Bozovic-Spasojevic, Ivana ;
Pugliano, Lina ;
Fumagalli, Debora ;
de Azambuja, Evandro ;
Viale, Giuseppe ;
Sotiriou, Christos ;
Piccart, Martine .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) :2794-+
[2]   Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed? [J].
Baker, Jennifer L. ;
Muhsen, Shirin ;
Zabor, Emily C. ;
Stempel, Michelle ;
Gemignani, Mary L. .
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) :336-342
[3]   Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation [J].
Bevilacqua, Jose Luiz B. ;
Kattan, Michael W. ;
Fey, Jane V. ;
Cody, Hiram S., III ;
Borgen, Patrick I. ;
Van Zee, Kimberly J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) :3670-3679
[4]   Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy [J].
Chen, Sheng ;
Huang, Liang ;
Chen, Can-Ming ;
Shao, Zhi-Ming .
ONCOTARGET, 2015, 6 (20) :18174-18182
[5]  
Costa Neto Olívio Feitosa, 2017, Rev. Col. Bras. Cir., V44, P391, DOI 10.1590/0100-69912017004014
[6]   Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial [J].
de Boniface, Jana ;
Frisell, Jan ;
Andersson, Yvette ;
Bergkvist, Leif ;
Ahlgren, Johan ;
Ryden, Lisa ;
Bagge, Roger Olofsson ;
Sund, Malin ;
Johansson, Hemming ;
Lundstedt, Dan .
BMC CANCER, 2017, 17
[7]   Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients - A metaanalysis [J].
Degnim, AC ;
Griffith, KA ;
Sabel, MS ;
Hayes, DF ;
Cimmino, VM ;
Diehl, KM ;
Lucas, PC ;
Snyder, ML ;
Chang, AE ;
Newman, LA .
CANCER, 2003, 98 (11) :2307-2315
[8]   Predictive Value of Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in Early Breast Cancer [J].
Ding, Jinhua ;
Jiang, Li ;
Wu, Weizhu .
MEDICAL SCIENCE MONITOR, 2017, 23 :4102-4108
[9]   Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial [J].
Donker, Mila ;
van Tienhoven, Geertjan ;
Straver, Marieke E. ;
Meijnen, Philip ;
van de Velde, Cornelis J. H. ;
Mansel, Robert E. ;
Cataliotti, Luigi ;
Westenberg, A. Helen ;
Klinkenbijl, Jean H. G. ;
Orzalesi, Lorenzo ;
Bouma, Willem H. ;
van der Mijle, Huub C. J. ;
Nieuwenhuijzen, Grard A. P. ;
Veltkamp, Sanne C. ;
Slaets, Leen ;
Duez, Nicole J. ;
de Graaf, Peter W. ;
van Dalen, Thijs ;
Marinelli, Andreas ;
Rijna, Herman ;
Snoj, Marko ;
Bundred, Nigel J. ;
Merkus, Jos W. S. ;
Belkacemi, Yazid ;
Petignat, Patrick ;
Schinagl, Dominic A. X. ;
Coens, Corneel ;
Messina, Carlo G. M. ;
Bogaerts, Jan ;
Rutgers, Emiel J. T. .
LANCET ONCOLOGY, 2014, 15 (12) :1303-1310
[10]   Triple-Negative Breast Cancer is Not Associated with Increased Likelihood of Nodal Metastases [J].
Gangi, Alexandra ;
Mirocha, James ;
Leong, Trista ;
Giuliano, Armando E. .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) :4098-4103